Sun Pharma Advanced Research Company Board of Directors
Get the latest insights into the leadership at Sun Pharma Advanced Research Company. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Mr. Dilip S Shanghvi | Chairman & Non-Exe.Director |
| Dr. T Rajamannar | Non Executive Director |
| Ms. Vidhi Shanghvi | Non Executive Director |
| Mr. Venkateswarlu Jasti | Independent Director |
| Ms. Bhavna Doshi | Independent Director |
| Dr. Ferzaan Engineer | Independent Director |
| Dr. Robert J Spiegel | Independent Director |
| Mrs. Rekha Warriar | Independent Director |
Sun Pharma Advanced Research Company Share price
SPARC
144.32
2.50 (-1.70%)NSE
BSE
Last updated on 4 Sep, 2025 | 15:59 IST
BUYSELL
Today's High
148.01
Today's Low
143.50
52 Week Low
109.30
52 Week High
241.00
The current prices are delayed, login to your account for live prices
LoginSun Pharma Advanced Research Company FAQs
The board at Sun Pharma Advanced Research Company consists of experienced professionals, including Mr. Dilip S Shanghvi , Dr. T Rajamannar , and others, overseeing the company’s strategic and corporate governance.
Directors at Sun Pharma Advanced Research Company are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Mr. Dilip S Shanghvi is the current chairman at Sun Pharma Advanced Research Company.
Executive directors at Sun Pharma Advanced Research Company are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, Sun Pharma Advanced Research Company adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At Sun Pharma Advanced Research Company, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.